Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases.
Nasdaq: AGIO
    
FAQs
Where is Agios’ corporate headquarters located?
Agios is headquartered at 88 Sidney Street, 2nd floor, Cambridge, MA 02139, U.S.

The main phone number is (617) 649-8600.
How is Agios’ stock traded?
Agios is traded on the NASDAQ global stock exchange under the ticker symbol AGIO, and its CUSIP number for the common stock is 00847X 104.
When did Agios go public?
Agios’ initial public offering (IPO) occurred on July 24, 2013.
When is Agios’ fiscal year-end?
Agios will end the fiscal year on December 31st.
Who is Agios’ transfer agent?
Communication regarding transfer requirements, lost certificates and changes of address should be directed to:

American Stock Transfer & Trust Company
(800) 937-5449 (Toll-free)
(718) 921-8124 (International)
http://www.amstock.com/new/InvestorServices/ShareholderServices.aspx

If delivering by mail:

American Stock Transfer & Trust Company Operations Center
Attn: Reorganization Department
P.O. Box 2042
New York, NY 10272-2042
  If delivering by hand or courier:

American Stock Transfer & Trust Company
Operations Center
Attn: Reorganization Department
6201 15th Avenue
Brooklyn, NY 11219
Who are Agios’ independent auditors?
Ernst & Young LLP
200 Clarendon Street
Boston, MA 02116
+1 617 266 2000
Where can I view Agios’ latest corporate news releases?
Agios press release archives can be viewed at http://investor.agios.com/phoenix.zhtml?c=251862&p=irol-news&nyo=0
How can I view documents that Agios has filed with the Securities & Exchange Commission (SEC),
including Forms 10-K and 10-Q?
Agios’ SEC filings can be viewed at http://investor.agios.com/phoenix.zhtml?c=251862&p=irol-sec or www.sec.gov
Whom should I contact if I have further questions?
You can submit queries to Agios’ investor relations department by contacting investors@agios.com.